A UAE registered investment consultancy firm’s core activities involve independent advisory, outsourced CIO, and direct investments. The firm acts as the consultant role to advise global family offices with their investment objectives. The firm looking for investment leads in early-stage life science industry. Companies who are looking to raise their series B – series C rounds would be the sweet spot. The firm typically invests in $5M-25M, which depends on the stage of development. The firm is also open to looking at earlier stage companies but the investment size might vary. The firm is looking for companies in the US (60%), China (20%), UK, Germany, India, and other countries with emerging life science technologies.
The firm is opportunistic in sectors and is willing to consider any indications.
The firm has no specific requirements for companies. The firm might take an observer seat or board seat in applicable cases.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply